Cargando…
Hepatitis C Virus Genotype 5 Variability in Treatment-Naïve Patients in South Africa
INTRODUCTION: Hepatitis C virus (HCV) genotype 5 was originally identified in South Africa, where it represents 35–60% of all HCV infections. There are limited data on resistance-associated variants (RAVs) in South Africa. Thus, we investigated variability within the NS3/NS4A, NS5A, and NS5B genes o...
Autores principales: | Maunye, Tshegofatso K., Gededzha, Maemu P., Blackard, Jason T., Rakgole, Johnny N., Selabe, Selokela G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353306/ https://www.ncbi.nlm.nih.gov/pubmed/37231989 http://dx.doi.org/10.1159/000528178 |
Ejemplares similares
-
Prediction of T-cell epitopes of hepatitis C virus genotype 5a
por: Gededzha, Maemu P, et al.
Publicado: (2014) -
Characterization of HCV Genotype 5a Envelope Proteins: Implications for Vaccine Development and Therapeutic Entry Target
por: Gededzha, Maemu Petronella, et al.
Publicado: (2014) -
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
por: Lukhwareni, Azwidowi, et al.
Publicado: (2020) -
A novel hepatitis B virus recombinant genotype D4/E identified in a South African population
por: Matlou, Mmatsatsi K., et al.
Publicado: (2019) -
Low seroprevalence of hepatitis E virus in pregnant women in an urban area near Pretoria, South Africa
por: Simani, Omphile E., et al.
Publicado: (2021)